Nutex Health receives Nasdaq exception until July 22 to effect reverse stock split and regain $1 bid price

Nutex Health Inc.

Nasdaq Hearings Panel granted Nutex exception until July 22, 2024 to execute reverse split and regain $1.00 minimum bid.
Stockholders approved reverse stock split (1-for-2 to 1-for-16); board to set exact ratio within one year.
Company had already done a 1-for-15 reverse split in April 2024 but still not compliant; delisting if not cured by July 22.
Annual meeting also elected all director nominees, approved executive compensation, and ratified Marcum LLP as auditor for FY2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.